Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03894553 · ClinicalTrials.gov registry record · NA
Focused Ultrasound (FUS) Mesencephalotomy for Head & Neck Cancer Pain
A NA study, sponsored by Jeff Elias, MD.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03894553: Completed NA study, sponsored by Jeff Elias, MD.
NCT03894553 is a NA study that has completed, run by Jeff Elias, MD. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03894553, a NA study, has completed, sponsored by Jeff Elias, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This proposed pilot study will investigate the safety and initial effectiveness of focused ultrasound lesioning of the contralateral mesencephalon for severe, opioid-resistant pain associated with head and neck cancer
Primary Outcome
Number of participants with treatment-related adverse events, as assessed from adverse event reporting throughout the 6 month study period. Additional measures of safety will be made with MRI evaluation.
Interventions
- DEVICE ExAblate Neuro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-06-22 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What the finished NCT03894553 record still lists
NCT03894553 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which ExAblate Neuro is the first listed.
NCT03894553 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03894553 about?
NCT03894553 is a clinical study titled "Focused Ultrasound (FUS) Mesencephalotomy for Head & Neck Cancer Pain". This proposed pilot study will investigate the safety and initial effectiveness of focused ultrasound lesioning of the contralateral mesencephalon for severe, opioid-resistant pain associated with head and neck cancer
What is the current status of trial NCT03894553?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-06-22. Estimated completion is 2025-08-31.
What interventions are being tested in trial NCT03894553?
The interventions under investigation include: ExAblate Neuro (DEVICE).
Who is sponsoring clinical trial NCT03894553?
This trial is sponsored by Jeff Elias, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03894553's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI